Explore IDEAYA Biosciences' FY 2024 financial report highlighting revenue drop, R&D surge, and strategic partnerships. Recommended investor stance: Hold.
Explore IDEAYA Biosciences' 8-K filing from February 13, 2025, revealing crucial insights for investors on corporate events impacting stock performance (Ticker: IDYA).
Explore IDEAYA Biosciences, Inc.'s 8-K filing detailing significant events on February 10, 2025. Understand investor implications and financial health insights.
Explore the vital details of IDEAYA Biosciences' 8-K report filed on December 27, 2024. Get insights on stock info, corporate changes, and more.